From: Serum MMP7, MMP10 and MMP12 level as negative prognostic markers in colon cancer patients
Patient characteristics | Number of patients (n = 78) | Mean overall Survival (months) | p-value |
---|---|---|---|
Gender | Â | Â | 0.37 |
 Male | 54 | 43.07 |  |
 Female | 24 | 49.62 |  |
Age at operation | Â | Â | 0.514 |
 <median = 64 years | 37 | 43.82 |  |
 ≥ median = 64 years | 41 | 42.68 |  |
Anastomotic leakage | Â | Â | 0.841 |
 Yes | 7 | 50.10 |  |
 No | 71 | 44.42 |  |
T-Stage | Â | Â | 0.495 |
 T1 | 2 | na |  |
 T2 | 8 | 32.8 |  |
 T3 | 54 | 40.04 |  |
 T4 | 14 | 38.28 |  |
N-Stage | Â | Â | 0.08 |
 N0 | 30 | 49.18 |  |
 N1 | 30 | 37.82 |  |
 N2 | 18 | 41.79 |  |
M-Stage | Â | Â | 0.01 |
 M0 | 55 | 46.69 |  |
 M1 | 23 | 36.55 |  |
Occurrence of liver metastases | Â | Â | 0.002 |
 Liver metastases (synchronous and metachronous) | 26 | 35.53 |  |
 No liver metastases | 52 | 51.51 |  |
Resection margin status | Â | Â | 0.121 |
 R0 | 68 | 45.98 |  |
 R1 | 4 | 35.25 |  |
 Rx | 6 | 29.02 |  |
Grading | Â | Â | 0.708 |
 G1 | 0 |  |  |
 G2 | 54 | 43.55 |  |
 G3 | 23 | 45.97 |  |
 Data not available | 1 |  |  |
Adjuvant chemotherapy | Â | Â | 0.083 |
 Yes | 47 | 40.66 |  |
 No | 31 | 44.20 |  |